Sector Watch: Healthcare - Sep 19 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $117.66 +0.15 0.13% | XBI: $95.57 +0.12 0.13% | Updated Sep 19, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| CSBR52WH Champions Oncology $156.1M |
13.98+1.68 910.1 K 6.0x |
14% | ||
| XTNT52WL Xtant Medical Holdings $59.3M |
4.51+0.53 140.2 K 6.4x |
13% | ||
| NTEC Intec Pharma $126.3M |
4.30+0.50 979.5 K 11.5x |
13% | ||
| NEPT52WH Neptune Technologies & Bioresources Inc $339.6M |
4.71+0.44 10.1 M 5.4x |
10% | ||
| FATE Fate Therapeutics $713.7M |
13.36+1.16 638.7 K 1.7x |
10% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| LFVN Lifevantage $149.2M |
10.59-1.61 508.9 K 2.0x |
-13% | ||
| NVTA Invitae $1.1B |
16.12-2.19 2.7 M |
-12% | ||
| AAC52WL AAC Holdings $166.0M |
6.75-0.49 317.6 K 1.6x |
-7% | ||
| UTMD Utah Medical Products $353.0M |
94.55-6.35 11.0 K |
-6% | ||
| PDEX52WH Pro-Dex $50.8M |
11.70-0.75 101.3 K 3.2x |
-6% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Parkinson's Disease - Pipeline Review, H1 2018 - ResearchAndMarkets.com | Business Wire [businesswire.com]Neptune Confirms its Name Change to Neptune Wellness Solutions Inc. [prnewswire.com]
Invitae to Present at the Ladenburg Thalmann 2018 Healthcare Conference [prnewswire.com]
Fate Therapeutics Announces Strategic Collaboration with ONO Pharmaceutical to Develop Off-the-Shelf, iPSC-derived CAR-T Cell Cancer Immunotherapies [globenewswire.com]
Xtant Medical Announces Amendments to Credit Facility and Issuance of Warrants NYSE:XTNT [globenewswire.com]
Neptune Receives Confirmation of Readiness Letter from Health Canada [prnewswire.com]
Seqster Makes Caregiving Easier With Launch of Caregiver View at Health 2.0 [prnewswire.com]
ORIC Pharmaceuticals Appoints Pratik Multani, MD, as Chief Medical Officer [prnewswire.com]
LifeVantage to Present at the Sidoti & Company Fall 2018 Conference [globenewswire.com]
Fate Therapeutics Enters into Exclusive License Agreement with Gladstone Institutes for CRISPR-based Cellular Reprogramming [globenewswire.com]
Inivata Strengthens Senior Leadership Ahead of Next Stage of Company Growth [globenewswire.com]
Invitae Appoints Chitra Nayak to its Board of Directors [prnewswire.com]
Champions Oncology Reports Record Quarterly Revenue of $6.2 Million [prnewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
